
Hannah Green
Life Sciences reporter at Boston Business Journal
Life sciences reporter @BosBizJournal | [email protected] | Alum: @GBHNews @DJNF @COMatBU @IfillCollege | WMass raised | Runs for fun
Articles
-
4 days ago |
yahoo.com | Hannah Green
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. Getting too stoned always has been—and always will be—an absolutely awful feeling. You reach that tipping point where your high turns from mellow to paranoid, and all of a sudden you’re stumbling uncontrollably down a rabbit hole of terrifying thoughts which all lead to the conclusion that the world is ending. Nobody likes how it feels.
-
6 days ago |
ca.news.yahoo.com | Hannah Green
The largest ever study investigating medical cannabis as a treatment for cancer, published this week in Frontiers in Oncology, found overwhelming scientific support for cannabis’s potential to treat cancer symptoms and potentially fight the course of the disease itself. The intention of the analysis was to solidify agreement on cannabis’s potential as a cancer treatment, said Ryan Castle, research director at the Whole Health Oncology Institute and lead author of the study.
-
6 days ago |
nbcboston.com | Hannah Green
Moderna Inc. is accusing a construction firm that worked on its Marlborough manufacturing facility of "defective design and construction of the core and shell of a building."The complaint filed by the Cambridge drugmaker in Suffolk Superior Court alleges that Burlington-based The Gutierrez Co. failed to properly design and construct the building at 149 Hayes Memorial Drive in Marlborough. More on this story from Boston Business Journal Copyright Boston Business Journal
-
1 week ago |
nbcboston.com | Hannah Green
A year that promised to be make-or-break for Alkermes' cancer-focused spinout has taken a terminal turn. Mural Oncology plc said on Tuesday it would stop clinical development of its lead cancer treatment, nemvaleukin, and look into strategic alternatives for the company. Mural has brought on Lucid Capital Markets LLC to explore its options. The biotech, which has its primary facilities in Waltham, is also laying off 90% of its workforce.
-
2 weeks ago |
irunfar.com | Hannah Green
Racing versus adventure running: This is a long-debated topic among many trail runners and one where I’ve struggled to find where my heart is happiest. Racing can be fun and motivating — training for a set goal you commit to by signing up and putting some money down. But sometimes racing lacks the creativity and adventure of dreaming up your own route, through a landscape that inspires you, and putting in the groundwork yourself to create your own adventure.
Journalists covering the same region

Lauren Matison
Travel Writer at Freelance
Lauren Matison primarily covers news in the New York and surrounding areas including parts of New Jersey and Connecticut, United States.

Ben Axelson
Commerce Reporter at Syracuse.com
Ben Axelson primarily covers news in New York City, New York, United States and surrounding areas.

Matthew Twist
Morning Executive Producer at WAVY-TV (Portsmouth, VA)
Matthew Twist primarily covers news in the Hampton Roads region of Virginia, United States, including cities like Norfolk and Virginia Beach.

Chris Johnson
Journalist at Connect Bridgeport
Chris Johnson primarily covers news in the Washington D.C. metropolitan area, including surrounding regions in Maryland and Virginia, United States.

Katie Inman
Reporter at WBIR-TV (Knoxville, TN)
Katie Inman primarily covers news in the Eastern Tennessee region, including areas around Knoxville and surrounding counties, United States.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 1K
- Tweets
- 1K
- DMs Open
- No

Scoop: Lyndra Therapeutics, a drug developer that spun out of the lab of MIT professor Bob Langer in 2015, is winding down operations after running out cash. https://t.co/yPdJXjW4aZ

BREAKING: Sage Therapeutics is rejecting the unsolicited acquisition offer from Biogen — but, it's open to other deals. https://t.co/hydtbnJvQn

The Massachusetts Life Sciences Center will no longer offer its angel investor tax credit, a program designed to drive early-stage investment in life science startups. Economic Development Secretary Yvonne Hao told the @BosBizJournal why it was cut. https://t.co/mobS1yrRff